A Phase 4 interventional study of Sugammadex Injection [Bridion] in Time of a TOF Ratio >0,9, sponsored by Erasme University Hospital. Completed at 1 site in Belgium. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-02-15.
Sponsored by Erasme University Hospital · Phase 4, Interventional, and Treatment
Time of appearance of TOF Ratio >0,9 with different doses of Sugammadex
Design: monocentric, prospective, controlled, randomized, double-blind study Inclusion criteria: women and men> 18 years old, elective surgery, BMI \<30, patients giving consent to free and informed participation in writing;
Exclusion criteria:
Course of the study :
All patients will benefit from general anesthesia. Anesthetic management
(1- 3mg / kg / IV propofol, 0.2 μg / IV sufentanil, 0.6 mg / kg rocuronium and maintenance anesthesia with sevoflurane) will be standardized for all patients.
Erasme University Hospital is the lead sponsor of 178 studies on the registry; 34 are open to participants now.
Counted across the registry records on this site, refreshed daily.
women and men> 18 years of age Elective Surgery BMI \<30, patients who gave consent to free and informed participation in writing
Exclusion Criteria:
Drug: Sugammadex Injection [Bridion]
Drug: Sugammadex Injection [Bridion]
Drug: Sugammadex Injection [Bridion]
Drug: Sugammadex Injection [Bridion]
Drug: Sugammadex Injection [Bridion]
Drug: Sugammadex Injection [Bridion]
Drug: Sugammadex Injection [Bridion]
Drug: Sugammadex Injection [Bridion]
Injection of 10mL of translucide solution
Evaluate the recovery time of the ratio 0.9.
Evaluate the recovery time of the ratio 0.9.
Time frame: 1 hour
Time of appearance of 4 responses to the TOF
Time of appearance of 4 responses to the TOF
Time frame: 1 hour
Evaluate the four-to-four ratio <0.7 after total recovery.
Evaluate the four-to-four ratio \<0.7 after total recovery.
Time frame: 1 hour
Watch time at the recovery room.
Watch time at the recovery room.
Time frame: 4 hours
Plan to share: Undecided
No publications or documents are linked to this record.
This study is completed, as verified in Apr 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Erasme University Hospital